In contrast, both AFP and Ferritin exhibited low AUC values (0.705 and 0.74, respectively) and low sensitivity (53.8% and 43.6%, respectively), which suggested that MRPL9 was superior to AFP and Ferritin in distinguishing HCC from healthy and benign groups. The gene discussed is MRPL9; the disease is hepatocellular carcinoma.